Institute of Organic Chemistry and Biochemistry AS CR

Did you know that the Institute of Organic Chemistry and Biochemistry AS CR is a global leader in antiviral drug development? Right here in Prague, this institution has made groundbreaking contributions. The Institute of Organic Chemistry and Biochemistry AS CR, often shortened to IOCB Prague, wasn’t always its current name. Founded in 1953, it started as a part of the Czech Technical University’s Faculty of Chemistry. Over time, it evolved, becoming a part of the Czechoslovak Academy of Sciences. Finally, in 1993, it was renamed to the Institute of Organic Chemistry and Biochemistry AS CR. What truly put this institution on the map was its research on acyclic nucleotide phosphonate antivirals (ANPs). Antonín Holý, a scientist at IOCB, led this pioneering work, collaborating with Erik De Clercq from the Rega Institute. Their discovery revolutionized the development of antiviral drugs. These drugs are now crucial for treating HIV and hepatitis B. In fact, one of the compounds developed here, tenofovir, became a key ingredient in globally recognized HIV/AIDS medications. You might recognize names like Viread, Truvada, and Atripla. The impact of the ANPs is immeasurable. IOCB Prague’s relentless work on these compounds didn’t just advance medical science. It also brought significant financial resources to the institute, allowing it to expand its facilities and further its research pursuits. Today, the institute continues to be a beacon of scientific exploration, drawing in some of the brightest minds in chemistry and biology.